|Bid||1.5200 x 800|
|Ask||1.6400 x 900|
|Day's Range||1.5000 - 1.5799|
|52 Week Range||1.4100 - 4.6800|
|Beta (5Y Monthly)||1.76|
|PE Ratio (TTM)||N/A|
|Earnings Date||Oct 31, 2022 - Nov 04, 2022|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||9.00|
Subscribe to Yahoo Finance Plus to view Fair Value for EKSO
Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...
SAN RAFAEL, Calif., Sept. 06, 2022 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company”), an industry leader in exoskeleton technology for medical and industrial use, today announced that Scott Davis, President and Chief Operating Officer, will be presenting virtually at the H.C. Wainwright 24th Annual Global Investment Conference taking place September 12-14, 2022. The pre-recorded presentation will be available to view on-demand as of 4:00 AM PT / 7:00 AM ET, Monday, S
Ekso Bionics (EKSO) delivered earnings and revenue surprises of 4.17% and 0.72%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?